Introduction: In the pre-antibiotic era up 10% of cases of infective endocarditis were due to Streptococcus pneumoniae, but this association is currently exceedingly rare.
Introduction
In the pre-antibiotic era up to 15% of all cases of infective endocarditis (IE) were due to S. pneumoniae, but currently <1%, almost all involving native valves. Recent data have demonstrated a relative increase in the incidence of prosthetic valves as a predisposing factor for IE, from ±13% in the 1970s and 1980s to presently 22-31% (Fefer et al. 2002) . We describe three patients with pneumococcal endocarditis diagnosed since 1997, one of whom had prosthetic valve endocarditis (PVE) which is the focus of the current paper and review 16 similar patients, previously published (Killen et al. 1970 , Bruyn et al. 1990 , Ugolini et al. 1986 , Aguado et al. 1993 , Hanson et al. 1993 , Cunningham and Sinha 1995 , Lefort et al. 2000 , Collazos et al. 1996 , Claes et al. 2000 , O'Brien et al. 2011 .
Patient #1
In March 2013, an 80-year old female patient presented because of an unexpected fall. She underwent mitral valve replacement 13 years earlier with a St Jude mechanical valve. She denied fever or any other complaint. Oral temperature was 37.6°C, mechanical heart sounds were heard, as well as a 2/6 apical systolic murmur. The physical examination was otherwise unremarkable.
Laboratory tests revealed a leucocyte count of 10.800/μL, hemoglobin 10.5 gm/dL, and normal liver and kidney function tests. Because of unexplained fever, three blood cultures were obtained, which grew Streptococcus pneumoniae, with a minimal inhibitory concentration (MIC) of <0.1 μg/mL. A trans-esophageal echocardiogram (TEE) revealed a 1.1 cm sized vegetation attached to the prosthetic mitral valve. In spite of the large vegetation and its presence on a mechanical valve it was decided not to operate, because of the patient's fragility. The patient was treated with intravenous ceftriaxone for six weeks, and she attained complete clinical and microbiological cure. 
Patient #2
In February 2006, an 81 year old fully alert woman was admitted because of swelling, erythema, local heat and pain in her left knee, which started several days after she fell. One year earlier she had undergone mitral valve repair because of severe mitral incompetence: after quadrangular resection annuloplasty was performed with a 30 mm ring. Physical examination revealed a temperature of 38°C, a 1/6 pan-systolic murmur at the apex, while the left knee was swollen, red and hot. The physical examination was otherwise unremarkable. The peripheral blood count was 9.400/μL, hemoglobin was 9.9 gm/dL and biochemistry was normal. Streptococcus pneumoniae was isolated from two blood cultures and from joint fluid; MIC was 0.02 μg/mL. The TEE demonstrated two vegetations < 1 cm in size attached to the posterior repaired mitral valve and ring. The patient received a six weeks course of ceftriaxone and completely recovered.
Patient #3
A 74 year male patient was admitted in 1996 because of an acute febrile illness. There were no localizing symptoms and physical examination was negative except a 2/6 systolic murmur. Streptococcus pneumoniae (MIC = 0.01 μg/mL), was isolated from two blood cultures. A TEE indicated moderate mitral regurgitation, exactly as found in a routine echocardiogram obtained two years earlier. The patient received two weeks of intravenous penicillin and completely recovered. During the subsequent six months he developed exertional dyspnea without fever. Echocardiography showed significantly worsened mitral regurgitation, but no vegetations were detected. He underwent an uneventful valve replacement with a biological prosthesis. Routine histologic examination revealed an ulcerated mitral valve, with fibrinous vegetation and inflammatory infiltrate. The patient was treated with ceftriaxone for four weeks and attained complete cure. In retrospect, it seems this patient suffered from pneumococcal endocarditis, partially treated with two weeks of intravenous penicillin and subsequently developed latent endocarditis and worsening mitral insufficiency (Shapiro et al. 2004 ).
Discussion
Pneumococcal endocarditis in the antibiotic era is rare and generally manifests acutely, similar to staphylococcal endocarditis, although rare instances of a more insidious course have been described. In several series of pneumococcal bacteremia in the antibiotic era the prevalence rate of endocarditis was reported, which ranges from 0.3%-3.4% (Bruyn et al. 1990, Cunningham and Sinha 1995) .
In our hospital 1694 patients have been diagnosed with pneumococcal bacteremia since 1997 (Table 1) . During this period only three patients, all aged >70, were diagnosed with endocarditis, constituting 0.18% of all cases of pneumococcal bacteremia. Of these 1694 cases, 395 (23%) occurred after age 70. Therefore, after the latter age the prevalence of endocarditis out of all cases of pneumococcal bacteremia was 0.7%.
One of our three pneumococcal endocarditis cases involved a prosthetic valve, another a repaired mitral valve and ring, possibly suggesting a higher propensity of S. pneumoniae to infect prosthetic rather than natural valves. This trend has not previously been reported: the Bruyn et al. reported five patients with pneumococcal endocarditis of whom one had PVE Bruyn et al. (1990) ), and Lefort et al. (2000) reported 30 cases with pneumococcal endocarditis, collected in a nation-wide survey of whom 4 (13%) had PVE.
A literature review detected another 16 cases of PVE with this organism (Table 2 ). The mean age of these 17 patients was 64 ± 14; 10 were female and 7 male. In most instances, symptom duration was short, < 6 days. Valve surgery was performed in 5 cases (29%) and 13 patients (78%) survived. UA, unavailable; each asterix* indicates one patient diagnosed that particular year with S. pneumoniae endocarditis. The difference in incidence of S. pneumoniae endocarditis between age 1-20 (0/871), adults aged 21-70 (0/428) and elderly (3/395 or 0.8%) was statistically insignificant. All patient-specific blood isolates of S. pneumoniae 1 (n, and as % of all patientspecific true-positive blood isolates 2 (i.e. excluding contaminants). 
